Risk-Based Quality Management
Every research program carries certain known and unknown risks. Risks is an integral part of drug discovery and development programs.
Our quality management system considers clinical trial as a whole for risk-based assessment from the perspectives of the clinical trial design, conduct, analysis, report, regulatory perspectives as well as archiving. Our interdisciplinary team is adept in clinical knowledge, project management, data management, IT support as well as biostatistics, pharmacovigilance and regulatory experts.